Health Opinion | To Prescribe or Not to Prescribe: Lecanemab Wins FDA Accelerated Approval Eli Pacheco Jan 13, 2023 0 Given the aducanumab (Aduhelm)/FDA investigation by Congress, the timing of the lecanemab…
Health Study Explores Impact of FDA Approval of Aducanumab on Trial Participation Eli Pacheco Dec 7, 2022 0 Elana Gotkine TUESDAY, Dec. 6, 2022 (HealthDay News) -- The U.S. Food and Drug Administration decision to approve aducanumab may have negatively…
Health Medicare Finalizes Limits on Aducanumab Coverage Eli Pacheco Apr 8, 2022 0 In its final decision about anti-amyloid monoclonal antibodies for Alzheimer's disease, CMS…
Health Aducanumab Data Finally Published, but Alzheimer’s Experts Spot Problems Eli Pacheco Mar 24, 2022 0 The long-awaited results of the twin phase III trials for aducanumab (Aduhelm), the controversial…
Health Alzheimer’s Concerns High; Aducanumab Knowledge Low Eli Pacheco Feb 15, 2022 0 Concerns about Alzheimer's disease were high, but knowledge about aducanumab (Aduhelm) was low,…
Health National Down Syndrome Organizations Launch Joint Effort To Change CMS Proposal… Eli Pacheco Feb 5, 2022 0 Atlanta, GA., Bismarck, ND., Burlington, MA., Denver, CO., Hoffman Estates, IL, NY, NY, Rockport, ME, Feb. 04, 2022 (GLOBE NEWSWIRE) -- Down Syndrome Affiliates in Action (DSAIA), GiGi’s…
Health Brain Inflammation Seen in Four of 10 Alzheimer’s Aducanumab Patients Eli Pacheco Nov 22, 2021 0 Brain inflammation known as amyloid-related imaging abnormalities (ARIA) occurred in about 40%…
Health Let Ethics Guide Aducanumab Prescribing, AAN Says Eli Pacheco Nov 19, 2021 0 With incomplete data to guide aducanumab (Aduhelm) prescribing, neurologists face ethical…
Health Update on Regulatory Review of Aducanumab in the European Union Eli Pacheco Nov 17, 2021 0 CAMBRIDGE, Mass., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Eisai Co., Ltd. (Tokyo, Japan) announced today an update on the ongoing review of the Marketing…
Health One Aducanumab Patient, Six Brain Edema Episodes Eli Pacheco Nov 9, 2021 0 A man treated with the recently approved Alzheimer's drug aducanumab (Aduhelm) had six…